GLP-3 R Phase 2: −28.7%143 Compounds · 5 Layers>98% HPLC All VialsFree Shipping $200+Third-Party Test ReportsResearch Use OnlyCAS Numbers VerifiedGHK-Cu: 4,000+ GenesGLP-3 R Phase 2: −28.7%143 Compounds · 5 Layers>98% HPLC All VialsFree Shipping $200+Third-Party Test ReportsResearch Use OnlyCAS Numbers VerifiedGHK-Cu: 4,000+ Genes
ARA-290 10mg

ARA-290 10mg

ARA-290

CAS: 1234356-69-4

$80.99$89.9910% OFFIn Stock

ARA-290 is a non-hematopoietic erythropoietin (EPO) peptide analog that activates the innate repair receptor (IRR) without stimulating red blood cell production. Studied for neuroprotection, peripheral nerve repair, and inflammatory pain. Phase 2 data in sarcoidosis neuropathy.

Specifications

Vial Size10mg
FormLyophilized Powder
Purity>98% HPLC
CAS1234356-69-4
Storage-20C long-term
Shop This Compound

For laboratory research use only. Not for human consumption.

Mechanism of Action

Activates the tissue-protective EPO receptor complex (IRR: EPOR/betacR heterodimer) independently of classical EPOR homodimer. This separation enables tissue-protective and anti-inflammatory effects without hematological EPO side effects.

Research FAQ

Why use ARA-290 instead of EPO for tissue protection?

ARA-290 activates only the tissue-protective IRR receptor, not the classical EPOR homodimer responsible for erythropoiesis and thrombotic risk. This allows neuroprotection research without hematological confounders.

Related Compounds